Skip to main content
SpringerLink
Log in

Staging Early Esophageal Cancer

  • Chapter
  • First Online:
Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 908))

Abstract

Staging esophageal cancer provides a standardized measure of the extent of disease that can be used to inform decisions about therapy and guide prognosis. For esophageal cancer, the treatment pathways vary greatly depending on stage of disease, and accurate staging is therefore crucial in ensuring the optimal therapy for each patient. For early esophageal cancer (T1 lesions), endoscopic resection can be curative and simultaneously gives accurate staging of depth of invasion. For tumors invading the submucosa or more advanced disease, comprehensive investigation is required to accurately stage the tumor and assess suitability for curative resection. A combined imaging approach of computed tomography (CT), positron emission tomography (PET), and endoscopic ultrasound (EUS) offers complementary diagnostic information and gives the greatest chance of accurate staging. Staging laparoscopy can identify peritoneal disease and small superficial liver lesions that could be missed on CT or PET, and alters management in up to 20 % of patients. Optical diagnostic techniques offer the prospect of further extending the possibilities of endoscopic staging in real time. Optical coherence tomography can image superficial lesions and could provide information on depth of invasion for these lesions. Real-time lymph node analysis using optical diagnostics such as Raman spectroscopy could be used to support immediate endoscopic therapy without waiting for results of cytology or further investigations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Allum WH, Blazeby JM, Griffin SM, et al. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60:1449–72. doi:10.1136/gut.2010.228254.

    Article  CAS  PubMed  Google Scholar 

  2. Rice TW, Rusch VW, Ishwaran H, et al. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer. 2010;116:3763–73. doi:10.1002/cncr.25146.

    Article  PubMed  Google Scholar 

  3. Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17:1721–4. doi:10.1245/s10434-010-1024-1.

    Article  PubMed  Google Scholar 

  4. Raimes S. Oesophagogastric surgery. A companion to specialist surgical practice. Fourth. Saunders Elsevier; 2009.

    Google Scholar 

  5. Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42. doi:10.1136/gutjnl-2013-305372.

    Article  PubMed  Google Scholar 

  6. Buskens CJ, Westerterp M, Lagarde SM, et al. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc. 2004;60:703–10. http://www.ncbi.nlm.nih.gov/pubmed/15557945 (accessed 13 Jun 2014).

    Article  PubMed  Google Scholar 

  7. Westerterp M, Koppert LB, Buskens CJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch. 2005;446:497–504. doi:10.1007/s00428-005-1243-1.

    Article  PubMed  Google Scholar 

  8. Stein HJ, Feith M, Bruecher BLDM, et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005;242:566–73. doi:10.1097/01.sla.0000184211.75970.85. discussion 573–5.

    PubMed  PubMed Central  Google Scholar 

  9. Liu L, Hofstetter WL, Rashid A, et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol. 2005;29:1079–85. http://www.ncbi.nlm.nih.gov/pubmed/16006804 (accessed 13 Jun 2014).

    PubMed  Google Scholar 

  10. Sepesi B, Watson TJ, Zhou D, et al. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg. 2010;210:418–27. doi:10.1016/j.jamcollsurg.2010.01.003.

    Article  PubMed  Google Scholar 

  11. Alvarez Herrero L, Pouw RE, van Vilsteren FG, et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy. 2010;42:1030–6. doi:10.1055/s-0030-1255858.

    Article  CAS  PubMed  Google Scholar 

  12. Barbour AP, Jones M, Brown I, et al. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol. 2010;17:2494–502. doi:10.1245/s10434-010-1025-0.

    Article  PubMed  Google Scholar 

  13. Rice TW, Zuccaro G, Adelstein DJ, et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg. 1998;65:787–92. doi:10.1016/S0003-4975(97)01387-8.

    Article  CAS  PubMed  Google Scholar 

  14. Pech O, May A, Manner H, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146:652–60.e1. doi:10.1053/j.gastro.2013.11.006.

    Article  PubMed  Google Scholar 

  15. Prasad GA, Wu TT, Wigle DA, et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett’s esophagus. Gastroenterology. 2009;137:815–23. doi:10.1053/j.gastro.2009.05.059.

    Article  PubMed  Google Scholar 

  16. Estrella JS, Hofstetter WL, Correa AM, et al. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Am J Surg Pathol. 2011;35:1045–53. doi:10.1097/PAS.0b013e318219ccef.

    Article  PubMed  Google Scholar 

  17. Conio M, Repici A, Cestari R, et al. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett’s esophagus: an Italian experience. World J Gastroenterol. 2005;11:6650–5.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Seewald S, Akaraviputh T, Seitz U, et al. Circumferential EMR and complete removal of Barrett’s epithelium: a new approach to management of Barrett’s esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc. 2003;57:854–9. doi:10.1016/S0016-5107(03)70020-0.

    Article  PubMed  Google Scholar 

  19. Ahmad NA, Kochman ML, Long WB, et al. Efficacy, safety, and clinical outcomes of endoscopic mucosal resection: a study of 101 cases. Gastrointest Endosc. 2002;55:390–6. doi:10.1067/mge.2002.121881.

    Article  PubMed  Google Scholar 

  20. Mino-Kenudson M, Brugge WR, Puricelli WP, et al. Management of superficial Barrett’s epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am J Surg Pathol. 2005;29:680–6. doi:10.1097/01.pas.0000154129.87219.fa.

    Article  PubMed  Google Scholar 

  21. Peters FP, Brakenhoff KPM, Curvers WL, et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett’s esophagus. Gastrointest Endosc. 2008;67:604–9. doi:10.1016/j.gie.2007.08.039.

    Article  PubMed  Google Scholar 

  22. Pouw RE, Seewald S, Gondrie JJ, et al. Stepwise radical endoscopic resection for eradication of Barrett’s oesophagus with early neoplasia in a cohort of 169 patients. Gut. 2010;59:1169–77. doi:10.1136/gut.2010.210229.

    Article  PubMed  Google Scholar 

  23. Konda VJA, Ross AS, Ferguson MK, et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett’s esophagus overestimated? Clin Gastroenterol Hepatol. 2008;6:159–64. doi:10.1016/j.cgh.2007.09.013.

    Article  PubMed  Google Scholar 

  24. Khanna LG, Gress FG. Preoperative evaluation of oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol. 2015;29:179–91. doi:10.1016/j.bpg.2014.12.005.

    Article  PubMed  Google Scholar 

  25. Kelly S, Harris KM, Berry E, et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut. 2001;49:534–9. doi:10.1136/gut.49.4.534.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Young PE, Gentry AB, Acosta RD, et al. Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus. Clin Gastroenterol Hepatol. 2010;8:1037–41. doi:10.1016/j.cgh.2010.08.020.

    Article  PubMed  Google Scholar 

  27. Larghi A, Lightdale CJ, Memeo L, et al. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett’s esophagus. Gastrointest Endosc. 2005;62:16–23. doi:10.1016/S0016-5107(05)00319-6.

    Article  PubMed  Google Scholar 

  28. Pech O, Günter E, Dusemund F, et al. Accuracy of endoscopic ultrasound in preoperative staging of esophageal cancer: results from a referral center for early esophageal cancer. Endoscopy. 2010;42:456–61. doi:10.1055/s-0029-1244022.

    Article  CAS  PubMed  Google Scholar 

  29. Pouw RE, Heldoorn N, Herrero LA, et al. Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases. Gastrointest Endosc. 2011;73:662–8. doi:10.1016/j.gie.2010.10.046.

    Article  PubMed  Google Scholar 

  30. Pech O, Günter E, Dusemund F, et al. Value of high-frequency miniprobes and conventional radial endoscopic ultrasound in the staging of early Barrett’s carcinoma. Endoscopy. 2010;42:98–103. doi:10.1055/s-0029-1243839.

    Article  CAS  PubMed  Google Scholar 

  31. Catalano MF, Sivak MV, Rice T, et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40:442–6. doi:10.1016/S0016-5107(94)70206-3.

    Article  CAS  PubMed  Google Scholar 

  32. Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc. 1997;45:474–9. doi:10.1016/S0016-5107(97)70176-7.

    Article  CAS  PubMed  Google Scholar 

  33. Rösch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am. 1995;5:537–47.

    PubMed  Google Scholar 

  34. Räsänen JV, Sihvo EIT, Knuuti MJ, et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol. 2003;10:954–60. doi:10.1245/ASO.2003.12.002.

    Article  PubMed  Google Scholar 

  35. Vazquez-Sequeiros E, Norton ID, Clain JE, et al. Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc. 2001;53:751–7. doi:10.1067/mge.2001.112741.

    Article  CAS  PubMed  Google Scholar 

  36. Wiersema MJ, Vilmann P, Giovannini M, et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology. 1997;112:1087–95.

    Google Scholar 

  37. Sandha GS, Severin D, Postema E, et al. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS. Gastrointest Endosc. 2008;67:402–9. doi:10.1016/j.gie.2007.09.006.

    Article  PubMed  Google Scholar 

  38. Keswani RN, Early DS, Edmundowicz SA, et al. Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer. Gastrointest Endosc. 2009;69:1210–7. doi:10.1016/j.gie.2008.08.016.

    Article  PubMed  Google Scholar 

  39. Pech O, May A, Günter E, et al. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett’s esophagus. Am J Gastroenterol. 2006;101:2223–9. doi:10.1111/j.1572-0241.2006.00718.x.

    Article  PubMed  Google Scholar 

  40. Bergeron EJ, Lin J, Chang AC, et al. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies. J Thorac Cardiovasc Surg. 2014;147:765–73. doi:10.1016/j.jtcvs.2013.10.003.

    Article  PubMed  Google Scholar 

  41. Meister T, Domagk D, Heinzow HS, et al. Miniprobe endoscopic ultrasound accurately stages esophageal cancer and guides therapeutic decisions in the era of neoadjuvant therapy: results of a multicenter cohort analysis. Surg Endosc. 2013;27:2813–9. doi:10.1007/s00464-013-2817-7.

    Article  PubMed  Google Scholar 

  42. Bulsiewicz WJ, Dellon ES, Rogers AJ, et al. The impact of endoscopic ultrasound findings on clinical decision making in Barrett’s esophagus with high-grade dysplasia or early esophageal adenocarcinoma. Dis Esophagus. 2014;27:409–17. doi:10.1111/j.1442-2050.2012.01408.x.

    Article  CAS  PubMed  Google Scholar 

  43. Godoy MCB, Bruzzi JF, Viswanathan C, et al. Multimodality imaging evaluation of esophageal cancer: staging, therapy assessment, and complications. Abdom Imaging. 2013;38:974–93. doi:10.1007/s00261-013-9986-7.

    Article  PubMed  Google Scholar 

  44. Rice TW. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am. 2000;10:471–85.

    CAS  PubMed  Google Scholar 

  45. Van Vliet EPM, Heijenbrok-Kal MH, Hunink MGM, et al. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer. 2008;98:547–57. doi:10.1038/sj.bjc.6604200.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Quint LE, Hepburn LM, Francis IR, et al. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer. 1995;76:1120–5. doi:10.1002/1097-0142(19951001)76:7<1120::AID-CNCR2820760704>3.0.CO;2-W.

    Article  CAS  PubMed  Google Scholar 

  47. Lowe VJ, Booya F, Fletcher JG, et al. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol. 2005;7:422–30. doi:10.1007/s11307-005-0017-0.

    Article  PubMed  Google Scholar 

  48. Lin J, Kligerman S, Goel R, et al. State-of-the-art molecular imaging in esophageal cancer management : implications for diagnosis, prognosis, and treatment. J Gastrointest Oncol. 2015;6:3–19. doi:10.3978/j.issn.2078-6891.2014.062.

    PubMed  PubMed Central  Google Scholar 

  49. Erasmus JJ, Munden RF. The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response. Semin Radiat Oncol. 2007;17:29–37. doi:10.1016/j.semradonc.2006.09.005.

    Article  PubMed  Google Scholar 

  50. Bruzzi JF, Munden RF, Truong MT, et al. PET/CT of esophageal cancer: its role in clinical management. Radiographics. 2007;27:1635–52. doi:10.1148/rg.276065742.

    Article  PubMed  Google Scholar 

  51. Cuellar SLB, Carter BW, Macapinlac HA, et al. Clinical staging of patients with early esophageal adenocarcinoma. J Thorac Oncol. 2014;9:1202–6. doi:10.1097/JTO.0000000000000222.

    Article  CAS  PubMed  Google Scholar 

  52. Kato H, Miyazaki T, Nakajima M, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer. 2005;103:148–56. doi:10.1002/cncr.20724.

    Article  PubMed  Google Scholar 

  53. Stahl A, Stollfuss J, Ott K, et al. FDG PET and CT in locally advanced adenocarcinomas of the distal oesophagus: clinical relevance of a discordant PET finding. Nuklear Medizin. 2005;44:249–55. doi:05060249 [pii].

    CAS  Google Scholar 

  54. Al-Taan OS, Eltweri A, Sharpe D, et al. Prognostic value of baseline FDG uptake on PET-CT in esophageal carcinoma. World J Gastrointest Oncol. 2014;6:139–44. doi:10.4251/wjgo.v6.i5.139.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Vallböhmer D, Hölscher AH, Dietlein M, Bollschweiler E, Baldus SE, Mönig SP, Metzger R, Schicha HSM. [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg. 2009;250:888–94.

    Article  PubMed  Google Scholar 

  56. Smith A, Finch MD, John TG, et al. Role of laparoscopic ultrasonography in the management of patients with oesophagogastric cancer. Br J Surg. 1999;86:1083–7. doi:10.1046/j.1365-2168.1999.01190.x.

    Article  CAS  PubMed  Google Scholar 

  57. Rau B, Hünerbein M. Diagnostic laparoscopy: indications and benefits. Langenbeck’s Arch Surg. 2005;390:187–96. doi:10.1007/s00423-004-0483-x.

    Article  Google Scholar 

  58. Nath J, Moorthy K, Taniere P, et al. Peritoneal lavage cytology in patients with oesophagogastric adenocarcinoma. Br J Surg. 2008;95:721–6. doi:10.1002/bjs.6107.

    Article  CAS  PubMed  Google Scholar 

  59. De Graaf GW, Ayantunde AA, Parsons SL, et al. The role of staging laparoscopy in oesophagogastric cancers. Eur J Surg Oncol. 2007;33:988–92. doi:10.1016/j.ejso.2007.01.007.

    Article  PubMed  Google Scholar 

  60. Compton CC, Byrd DR, Garcia-Aguilar J, et al., editors. AJCC Cancer Staging Atlas. New York, NY: Springer; 2012. doi: 10.1007/978-1-4614-2080-4.

    Google Scholar 

  61. Li-Qing Y. New endoscopic diagnosis and treatment options for early esophageal cancer. J Gastrointest Dig Syst. 2012.

    Google Scholar 

  62. Pierce MC, Javier DJ, Richards-Kortum R. Optical contrast agents and imaging systems for detection and diagnosis of cancer. Int J Cancer. 2008;123(9):1979–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Testoni PA, Mangiavillano B. Optical coherence tomography in detection of dysplasia and cancer of the gastrointestinal tract and bilio-pancreatic ductal system. World J Gastroenterol. 2008;14(42):6444.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Tsai T-H, Fujimoto JG, Mashimo H. Endoscopic optical coherence tomography for clinical gastroenterology. Diagnostics. 2014;4(2):57–93.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Isenberg G, et al. Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett’s esophagus: a prospective, double-blinded study. Gastrointest Endosc. 2005;62(6):825–31.

    Article  PubMed  Google Scholar 

  66. Evans JA, et al. Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett’s esophagus. Clin Gastroenterol Hepatol. 2006;4(1):38–43.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Qi X, et al. Image analysis for classification of dysplasia in Barrett’s esophagus using endoscopic optical coherence tomography. Biomed Optic Express. 2010;1(3):825–47.

    Article  Google Scholar 

  68. Chen Y, et al. Ultrahigh resolution optical coherence tomography of Barrett's esophagus: preliminary descriptive clinical study correlating images with histology. Endoscopy. 2007;39(7):599–605.

    Article  CAS  PubMed  Google Scholar 

  69. Jäckle S, et al. In vivo endoscopic optical coherence tomography of esophagitis, Barrett's esophagus, and adenocarcinoma of the esophagus. Endoscopy. 2000;32(10):750–5.

    Article  PubMed  Google Scholar 

  70. Li XD, et al. Optical coherence tomography: advanced technology for the endoscopic imaging of Barrett's esophagus. Endoscopy. 2000;32(12):921–30.

    Article  CAS  PubMed  Google Scholar 

  71. Lightdale CJ. Advanced imaging for GI endoscopy. Gastrointest Endosc Clin N Am. 2013;23(3):xiii–xiv.

    Article  Google Scholar 

  72. Robles LY, Satish S, Fisichella PM. Emerging enhanced imaging technologies of the esophagus: spectroscopy, confocal laser endomicroscopy, and optical coherence tomography. J Surg Res. 2015;195(2):502–14.

    Article  PubMed  Google Scholar 

  73. Singh R, Yeap SP. Endoscopic imaging in Barrett’s esophagus. Expert Rev Gastroenterol Hepatol. 2014:1–11

    Google Scholar 

  74. Wang KK. Detection and staging of esophageal cancers. Curr Opin Gastroenterol. 2004;20(4):381.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Hatta W, et al. A prospective comparative study of optical coherence tomography and EUS for tumor staging of superficial esophageal squamous cell carcinoma. Gastrointest Endosc. 2012;76(3):548–55.

    Article  PubMed  Google Scholar 

  76. Hatta W, et al. Optical coherence tomography for the staging of tumor infiltration in superficial esophageal squamous cell carcinoma. Gastrointest Endosc. 2010;71(6):899–906.

    Article  PubMed  Google Scholar 

  77. McLaughlin RA, et al. Imaging of human lymph nodes using optical coherence tomography: potential for staging cancer. Cancer Res. 2010;70(7):2579–84.

    Article  CAS  PubMed  Google Scholar 

  78. McLaughlin RA, et al. Imaging of breast cancer with optical coherence tomography needle probes: feasibility and initial results. Selected topics in Quantum electronics. IEEE J. 2012;18(3):1184–91.

    CAS  Google Scholar 

  79. Standish BA, et al. Interstitial Doppler optical coherence tomography as a local tumor necrosis predictor in photodynamic therapy of prostatic carcinoma: an in vivo study. Cancer Res. 2008;68(23):9987–95.

    Article  CAS  PubMed  Google Scholar 

  80. Iftimia NV, et al. Spectral-domain low coherence interferometry/optical coherence tomography system for fine needle breast biopsy guidance. Rev Sci Instrum. 2009;80(2):024302.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Kirtane TS, Wagh MS. Endoscopic optical coherence tomography (OCT): advances in gastrointestinal imaging. Gastroenterol Res Pract. 2014;2014:376367.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Almond LM, et al. Assessment of a custom-built Raman spectroscopic probe for diagnosis of early oesophageal neoplasia. J Biomed Opt. 2012;17(8):0814211–6.

    Article  Google Scholar 

  83. Almond LM, et al. Endoscopic Raman spectroscopy enables objective diagnosis of dysplasia in Barrett's esophagus. Gastrointest Endosc. 2014;79(1):37–45.

    Article  PubMed  Google Scholar 

  84. Almond LM, et al. Real-time disease detection using spectroscopic diagnosis. Biomed Spectros Imag. 2014;3(3):197–202.

    Google Scholar 

  85. Bergholt MS, et al. In vivo diagnosis of esophageal cancer using image-guided Raman endoscopy and biomolecular modeling. Technol Cancer Res Treat. 2011;10(2):103–12.

    CAS  PubMed  Google Scholar 

  86. Bergholt MS et al. Raman endoscopy for objective diagnosis of early cancer in the gastrointestinal system. J Gastroint Dig Syst. 2013;S1:008.

    Google Scholar 

  87. Isabelle M, et al. Lymph node pathology using optical spectroscopy in cancer diagnostics. J Spectros. 2008;22(2–3):97–104.

    Article  CAS  Google Scholar 

  88. Lloyd GR, et al. Discrimination between benign, primary and secondary malignancies in lymph nodes from the head and neck utilising Raman spectroscopy and multivariate analysis. Analyst. 2013;138(14):3900–8.

    Article  CAS  PubMed  Google Scholar 

  89. Horsnell JD, et al. Raman spectroscopy—a potential new method for the intra-operative assessment of axillary lymph nodes. Surgeon. 2012;10(3):123–7.

    Article  PubMed  Google Scholar 

  90. Horsnell J, et al. Intra-operative Sentinel Lymph Node Assessment-How many patients will avoid a second operation? Eur J Surg Oncol. 2012;38(5):459–60.

    Article  Google Scholar 

  91. Smith J, et al. Raman spectral mapping in the assessment of axillary lymph nodes in breast cancer. Technol Cancer Res Treat. 2003;2(4):327–31.

    Article  CAS  PubMed  Google Scholar 

  92. Day JCC, Stone N. A subcutaneous Raman needle probe. Appl Spectrosc. 2013;67(3):349–54.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Upper GI Surgery Department, Gloucestershire Royal Hospital, Gloucester, UK

    O. J. Old & H. Barr

  2. Biophotonics Research Unit, Gloucestershire Royal Hospital, Gloucester, UK

    O. J. Old & M. Isabelle

Authors
  1. O. J. Old
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Isabelle
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Barr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. J. Old .

Editor information

Editors and Affiliations

  1. UCL Cancer Institute, University College London, London, United Kingdom

    Marnix Jansen

  2. Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom

    Nicholas A. Wright

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Old, O.J., Isabelle, M., Barr, H. (2016). Staging Early Esophageal Cancer. In: Jansen, M., Wright, N. (eds) Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract. Advances in Experimental Medicine and Biology, vol 908. Springer, Cham. https://doi.org/10.1007/978-3-319-41388-4_9

Download citation

Publish with us

Policies and ethics

Search

Navigation